hotspot -WSS

hotspot

author：fashion 2025-10-02 00:19:03 - browse：5451

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： The best solution to the drug shortages problem

Wikipedia

WSS

Medicare’s new pay boost for primary care is angering specialists

Drastic changes should bring profitability, startup health insurers say

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Readout Newsletter: Zepbound, Valneva's vaccine, and more

After decades in use, heart stents finally beat placebo

A letter from the executive editor: STAT UnitedHealth investigation

Wikipedia

hotspot

explore

As demand for Covid shots wanes, Moderna seeks its next success

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ventyx halts psoriasis drug development after lackluster trial results

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Activists slam private health insurers over coverage restrictions

What is STAT's opinion section for?

Virginia high school admissions case could be legal follow

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

leisure time

Healthy food access boosts outcomes in two studies

Wegovy trial has doctors encouraged over new possibilities

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Man killed during FBI raid in connection with threats against Biden, other officials

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Ventyx halts psoriasis drug development after lackluster trial results

focus

Wikipedia

hotspot

focus